Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
5
×
roche
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
5
×
wisconsin blog main
wisconsin top stories
cancer
clinical trials
fda
indiana blog main
indiana top stories
investing
crispr-cas9
deals
startups
alder biopharmaceuticals
amgen
biotech ipos
bridgebio
What
roundup
5
×
bio
ahead
asco
crispr
days
drug
advantages
alliance
ambien
american
annual
attendees
attention
bar
big
biotech
bosley's
bosley’s
branded
bridge
brings
bristol
bucks
buy
calls
camp’s
cancer
cas
cash
ceo
changing
chicago
choices
city
clinical
color
combinations
commissioner
community’s
Language
unset
Current search:
roche
×
photo
×
" raleigh-durham top stories "
×
roundup
×
" vertex pharmaceuticals "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More